CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	9 Months Ended
Sep. 30, 2013	Sep. 30, 2012
Cash flows from operating activities:
Net income	$ 161,780	$ 35,011
Adjustments to reconcile net income to net cash provided by operating activities:
Provision (credit) for loan and lease losses	(9,977)	(16,602)
Depreciation and amortization	4,528	4,760
Write down of assets		2,586
Write down of other real estate, net of gain on sale	(7,989)	3,032
Amortization of other intangible assets	5,994	7,490
Net amortization of investment securities	10,766	11,764
Share-based compensation	3,168	2,509
Net gain on investment securities		(789)
Net gain on sales of residential loans	(8,492)	(11,084)
Proceeds from sales of loans held for sale	545,199	675,799
Originations of loans held for sale	(510,861)	(650,920)
Equity in earnings of unconsolidated subsidiaries	(733)	(386)
Increase in cash surrender value of bank-owned life insurance	(1,492)	(4,203)
Deferred income taxes	(115,683)
Premium paid on repurchases of preferred stock of subsidiaries	1,895
Net change in other assets and liabilities	(8,425)	(16,279)
Net cash provided by operating activities	69,678	42,688
Cash flows from investing activities:
Proceeds from maturities of and calls on investment securities available for sale	387,409	315,723
Proceeds from sales of investment securities available for sale		130,076
Purchases of investment securities available for sale	(501,502)	(457,041)
Proceeds from maturities of and calls on investment securities held to maturity	9,980	689
Purchases of investment securities held to maturity	(4,595)	(163,498)
Net loan originations	(258,612)	(58,467)
Purchases of loan portfolios	(37,104)
Proceeds from sales of loans originated for investment	10,679	10,340
Proceeds from sale of other real estate	16,375	14,960
Proceeds from bank-owned life insurance		1,997
Purchases of premises and equipment	(3,920)	(2,770)
Distributions from unconsolidated subsidiaries	553	455
Contributions to unconsolidated subsidiaries	(9,050)
Proceeds from redemption of FHLB stock	1,302	434
Net cash used in investing activities	(388,485)	(207,102)
Cash flows from financing activities:
Net increase in deposits	225,492	178,062
Repayments of long-term debt	(13)	(50,013)
Net increase (decrease) in short-term borrowings	28,000	(34)
Cash dividends paid on common stock	(3,367)
Repurchases of preferred stock of subsidiaries	(11,781)
Net cash provided by financing activities	238,331	128,015
Net decrease in cash and cash equivalents	(80,476)	(36,399)
Cash and cash equivalents at beginning of period	177,375	257,072
Cash and cash equivalents at end of period	96,899	220,673
Cash paid during the period for:
Interest	17,436	4,489
Income taxes	5	1
Cash received during the period for:
Income taxes		396
Supplemental disclosure of noncash investing and financing activities:
Net change in common stock held by directors' deferred compensation plan	39	27
Net reclassification of loans to other real estate	3,461	2,973
Net reclassification of loans held for sale to other real estate		716
Net transfer of loans to loans held for sale		1,487
Net transfer of investment securities available for sale to held to maturity	$ 101,669

The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets, and the amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.

No definition available.